Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

55
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
55
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

41
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

45
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
45
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential impact of institutional procedural volume on outcomes of transcatheter and surgical strategies for concomitant aortic stenosis and coronary artery disease: a nationwide registry study.

Cardiovascular intervention and therapeutics·2026
Same author

Perioperative Outcomes of Surgical Left Atrial Appendage Occlusion During Cardiac Surgery.

Brazilian journal of cardiovascular surgery·2026
Same author

Trends and In-Hospital Outcomes of Conventional Transvenous Pacemaker vs. Leadless Pacemaker　- Nationwide Matched Control Study Using the JROAD-DPC Database.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Characteristics and Outcomes of Multisystemic Inflammation in Patients Clinically Diagnosed With Non-COVID-19-Related Fulminant Myocarditis.

Circulation reports·2026
Same author

Epidemiology of Cardiovascular Disease in Pregnancy in Japan　- Analysis of a Nationwide Perinatal Database 2014-2023.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Homozygous SGCB splice-site variant causes isolated dilated cardiomyopathy through sarcoglycan complex destabilization in East Asians.

The Journal of clinical investigation·2026
Same journal

Non-Culprit Lesion Plaque Vulnerability Progression and Regression Assessed by Serial Optical Coherence Tomography Imaging.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same journal

Reduction in Heart Failure Hospitalizations Through Real-World HeartLogic<sup>TM</sup> Alert Response　- A Multicenter Study in Japan.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same journal

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same journal

Cardiac Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia　- Target Definition, Dose Distribution, and Clinical Trajectory.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same journal

Myocardial Perfusion and Fluorodeoxyglucose Uptake Patterns in Cardiac Sarcoidosis Stratified by Diagnostic Category and Systemic Involvement.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same journal

A High Level of Calculated Small Dense Low-Density Lipoprotein Cholesterol Is an Independent Risk Factor for the Progression of Renal Impairment.

Circulation journal : official journal of the Japanese Circulation Society·2026
See all related articles

Related Experiment Video

Updated: Sep 11, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

872

Implementing the Certified Heart Failure Educator System in Japan　- Initial Experience.

Koshiro Kanaoka1, Yoshitaka Iwanaga1,2, Yoko Sumita1

  • 1Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center.

Circulation Journal : Official Journal of the Japanese Circulation Society
|August 12, 2025
PubMed
Summary
This summary is machine-generated.

The Certified Heart Failure Educator (CHFE) program successfully launched in Japan, with CHFE-affiliated hospitals showing better heart failure (HF) management and outcomes. This initiative improved patient care in high-quality healthcare facilities.

Keywords:
Certified Heart Failure EducatorHeart failureQuality of care

More Related Videos

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.5K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

Related Experiment Videos

Last Updated: Sep 11, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

872
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.5K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

Area of Science:

  • Cardiology
  • Healthcare Management
  • Medical Education

Background:

  • The Japanese Circulation Society (JCS) initiated a Certified Heart Failure Educator (CHFE) program in 2021.
  • Limited data exists on the program's initial impact and its relation to hospital quality.
  • This study evaluates the early implementation of the CHFE program and its association with hospital quality metrics.

Purpose of the Study:

  • To describe the initial implementation experience of the CHFE program in Japan.
  • To assess the association between the presence of CHFEs and hospital quality measures for heart failure (HF) care.
  • To evaluate the impact of CHFEs on patient outcomes in acute HF hospitalization.

Main Methods:

  • Retrospective analysis of CHFE certification data (2021-2024) and Japanese Registry of All Cardiac and Vascular Diseases-Diagnosis Procedure Combination data (2021).
  • Examined the number of CHFEs, hospital affiliation, and patient data for acute HF admissions.
  • Statistical adjustment for baseline characteristics to assess the association between CHFE presence and quality/mortality outcomes.

Main Results:

  • The number of CHFEs grew significantly from 1,771 in 2021 to 6,603 in 2024, with most affiliated with hospitals.
  • Hospitals with CHFEs were more likely to be JCS training hospitals and had higher HF hospitalization rates and cardiology beds.
  • Admission to facilities with CHFEs was linked to improved process measure achievement and reduced in-hospital mortality for acute HF patients.

Conclusions:

  • The CHFE system has been successfully implemented and positively impacts heart failure management, particularly in high-quality hospitals.
  • The findings suggest the CHFE program contributes to enhanced HF care and patient outcomes.
  • This study provides valuable insights for refining future strategies related to the CHFE program and HF management.